Histoindex

HistoIndex delivers stain-free AI-powered digital pathology for fibrosis, combining Second Harmonic Generation imaging with explainable AI to visualise and quantify tissue features beyond conventional methods. Its FibroSIGHT platform and qFibrosis analytics support translation from preclinical to clinical stages, accelerating drug development and regulatory review through imaging and analytics services for pharma, biotech and CROs. Focused on precision diagnostics and disease progression prediction in fibrosis.

Histoindex is VC-Backed and has raised funding across Series A2 and Series A1 rounds. It is backed by SNS Holdings and Aligent Spring.

Alternatives.pe tracks Histoindex's funding history, valuation trends, ownership structure, and transaction activity over time.

You're on a preview of a profileGet a free trial to view it in full

Last Updated: 2026-07-21

You're on a preview of a profileGet a free trial to view it in full

Last Updated: 2026-07-21

Loading, please wait...

All information here may not be reproduced without explicit written permission from Alternatives.pe.

Glossary

Histoindex

Histoindex

Documents

Employee Count

Key Team Members

Documents

Employee Count

Key Team Members